Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Sankyo prepares neuraminic acid compounds useful for preventing the flu

May 22, 1998

New penems in development at Menarini and Lusofarmaco

May 21, 1998

Phosphonate nucleotides with antiviral/antitumor activity from Mitsubishi

May 21, 1998

Helicase-primase, an enzyme target for the design of new antiviral agents

May 19, 1998

Antiherpes agent will enter phase II, Abbott says

May 19, 1998

Eisai selects new triazole antifungal for further development

May 15, 1998

Scriptgen and Boston University synthesize new antibiotics

May 15, 1998

Antifungal agents disclosed by Nippon Soda

May 15, 1998

Microbial product acts as ergosterol biosynthesis inhibitor in in vitro screen

May 14, 1998

Neuraminic acid derivatives claimed by Sankyo for influenza

May 14, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...